Related Experiment Video
Updated: Jun 11, 2026
09:15
In Vitro Thrombosis Test for Ventricular Assist Devices
Published on: March 21, 2025
In vitro methods of evaluating antithrombotics and thrombolytics
1Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USA.
Methods in Molecular Biology (Clifton, N.J.)
|July 10, 2010
Summary
Platelets are vital for stopping bleeding and are key players in arterial thrombotic disorders like heart attack and stroke. Understanding platelet function is crucial for developing new treatments for these conditions.
Area of Science:
- Cardiovascular Science
- Hematology
- Pathophysiology
Background:
- Platelets are essential for primary hemostasis, forming plugs at vascular injury sites.
- Platelets significantly contribute to arterial thrombotic disorders, such as unstable angina, myocardial infarction, and stroke.
- Atherosclerotic plaque rupture or erosion triggers platelet adhesion and thrombus formation, leading to occlusive events.
Purpose of the Study:
- To review the critical role of platelets in hemostasis and thrombosis.
- To highlight the involvement of platelets in the pathogenesis of arterial thrombotic diseases.
- To discuss methods for assessing platelet function and the efficacy of antithrombotic agents.
Main Methods:
- Literature review of platelet function in hemostasis and thrombosis.
- Analysis of pathophysiological mechanisms in atherosclerotic plaque disruption.
- Overview of diagnostic and therapeutic assessment methodologies.
Main Results:
- Platelets are central to both normal hemostasis and pathological thrombosis.
- Platelet activation at disrupted atherosclerotic plaques is a key event in arterial thrombotic disorders.
- Various ex vivo and in vitro methods exist to evaluate platelet aggregation and the effectiveness of antithrombotic drugs.
Conclusions:
- Platelet activity is a critical target for managing arterial thrombotic diseases.
- Further research into platelet function can lead to improved therapeutic strategies.
- Accurate assessment of platelet function and drug efficacy is vital for clinical practice.
Related Concept Videos
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:13In Vitro Drug Dissolution: Compendial Testing Models I
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
01:09In Vitro Drug Dissolution: Compendial Testing Models II
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients, maintaining...
01:17Equivalence: In Vitro and In Vivo Bioequivalence
Bioequivalence studies are crucial in evaluating whether new drugs can match an approved one regarding pharmacological effects and clinical performance. These studies test if drugs, despite different dosage forms, share identical plasma concentration-time profiles. Three types of equivalence are central to these studies: chemical, pharmaceutical, and therapeutic. Chemical equivalence indicates that two or more drug products contain identical active ingredients in equal amounts. Pharmaceutical...